The revenue stands at ₹1,421.64 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.40 per cent from ₹1,374.84 crore. This corresponds to a year-on-year *(YoY) growth of 21.47 per cent.
Operating Profit stands at ₹333.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.77 per cent from ₹382.24 crore. This corresponds to a year-on-year *(YoY) growth of 12.20 per cent.
PBDT stands at ₹392.48 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.39 per cent from ₹402.11 crore. This corresponds to a year-on-year *(YoY) growth of 26.94 per cent.
Profit Before Tax stands at ₹347.11 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.20 per cent from ₹358.60 crore. This corresponds to a year-on-year *(YoY) growth of 28.84 per cent.
Net Profit stands at ₹266.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.58 per cent from ₹273.77 crore. This represents a 18.40 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | 0.66% | 2.12% | -2.85% | 1.49% | 13.68% | 14.67% |
| Anthem Bioscienc | 2.04% | 1.10% | -2.81% | 15.45% | 15.74% | 4.33% |
| Ipca Labs. | 1.66% | 8.99% | 7.16% | 9.07% | 13.26% | 20.05% |
| Gland Pharma | 1.96% | -0.14% | 18.33% | 35.26% | 32.71% | 37.86% |
| Glaxosmi. Pharma | -0.01% | -1.01% | -11.07% | -14.09% | -15.38% | -36.21% |
| J B Chemicals & | 1.84% | 1.97% | -1.74% | 4.81% | 20.73% | 29.39% |
| Emcure Pharma | 1.42% | 3.67% | 4.89% | 15.83% | 24.34% | 32.93% |
Chairman (Non-Executive) : Mannalal B Agrawal
Vice Chairman : Madhusudan B Agrawal
Managing Director : Yogesh Agrawal
Vice President & Company Secretary : Gaurang Shah
Joint Managing Director : Rajesh M Agrawal
Independent Director : David Rasquinha
Independent Director : Medha Joshi
Independent Director : Simi Thapar
Independent Director : Rajesh Shashikant Dalal